A NOVEL ORALLY AVAILABLE EP4 AGONIST, KAG-308, INHIBITS AZOXYMETHANE/DEXTRAN SULFATE SODIUM-INDUCED COLITIS AND COLORECTAL CARCINOGENESIS IN MICE

(1) KAKEN PHARMACEUTICAL CO.,LTD.

(2) ASAHI GLASS CO., LTD.

(3) KANAZAWA MEDICAL UNIV



This item was part of the IBD II session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A302